Home/Filings/4/0001613103-25-000110
4//SEC Filing

Blomquist Denise L. 4

Accession 0001613103-25-000110

CIK 0001613103other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 4:15 PM ET

Size

10.3 KB

Accession

0001613103-25-000110

Insider Transaction Report

Form 4
Period: 2025-07-28
Blomquist Denise L.
Chief Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-07-28+1,2781,278 total
    Exercise: $91.97Exp: 2035-07-28Ordinary Shares (1,278 underlying)
  • Award

    Performance Share Units

    2025-07-28+2,2022,202 total
    Performance Share Unit (2,202 underlying)
  • Award

    Ordinary Shares

    2025-07-28+2,20212,425 total
Footnotes (6)
  • [F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
  • [F2]Includes 52 shares acquired through dividend reinvestment and 28 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.
  • [F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  • [F4]Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
  • [F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,202 shares will be issued. If maximum performance metrics are achieved, 4,404 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  • [F6]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0002061393

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:15 PM ET
Size
10.3 KB